mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.007 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.007 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.008 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.009 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.009 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.01 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.01 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |